欧洲和中东慢性疼痛脊髓刺激装置市场规模和预测(2020 - 2030)、全球和地区份额、趋势和增长机会分析报告范围:按产品类型(充电式和非充电式)、应用(失败返回)综合征、复杂区域疼痛综合征、退行性椎间盘疾病等)、最终用户 [医院、门诊手术中心 (ASC) 等] 和区域分析

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 204    |    Report Code: BMIRE00029370    |    Category: Life Sciences

Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market
欧洲和中东用于慢性疼痛的脊髓刺激装置市场预计将从2022年的8.9266亿美元增长到2030年的15.7367亿美元;预计 2022 年至 2030 年复合年增长率为 7.3%。\\n\\n脊髓损伤数量的增加以及欧盟 (EU) 创新治疗方法的可用性是推动欧洲和中东脊髓损伤的几个因素促进慢性疼痛市场增长的刺激装置。 \\n\\n 脊髓刺激装置是一种植入装置,可将低水平的电流直接发送到脊髓以缓解疼痛。脊髓刺激器主要用于非手术疼痛治疗方案未能提供足够缓解后。此外,脊髓刺激器可以改善整体生活和睡眠质量,并减少对止痛药的需求。它通常与其他疼痛管理治疗一起使用。 \\n\\n欧盟创新治疗的可用性\\n\\n根据欧盟委员会发布的一份报告,SCI 会导致运动损伤,包括感觉丧失、慢性疼痛和其他运动功能障碍。因此,欧盟 (EU) 正在针对 SCI 患者开展多项康复计划。脊髓修复项目(SCRP)就是这样一个例子,它是欧盟科学家之间的多学科合作。 SCRP 负责恢复身体运动,例如运动功能或 SCI 后的运动。根据该计划,开发了一种实验装置 MotoRater 并注册了商标,用于啮齿类动物运动的标准化测试,作为临床测试的一部分。这些啮齿动物被用来识别和表征兴奋性中枢模式发生器(CPG)神经元(例如负责运动的 EphA4)的细胞特性。 CPG 是脊髓中的一个神经回路,通过 CPG 神经元之间的相互作用及其突触相互作用来刺激节律运动。通过会议和代表大会展示临床研究成果;已申请并公布专利。因此,欧盟在脊髓疾病治疗方面的持续创新有助于改善数百万脊髓损伤患者的活动能力和生活质量。\\n\\n多家生物制药公司正在开发治疗脊髓损伤的创新产品。 BioArctic 是一家瑞典生物制药公司,致力于开发中枢神经系统 (CNS) 疾病的治疗方法。例如,2019 年 2 月,BioArctic 开发了“SC0806”,这是一种可生物降解的医疗设备,可以通过手术植入受伤的脊髓。植入“SCO806”后,该装置引导神经纤维穿过脊髓损伤区域。竞争者推出的此类治疗 SCI 的创新产品推动了欧洲和中东慢性疼痛市场脊髓刺激装置的增长。\\n\\n \\n\\n市场趋势\\n\\n基于植入物的再生和创新治疗方法\\n\\n马德里自治区声称是欧盟第一个使用细胞和再生疗法提供脊髓损伤治疗的机构。再生医学包括从 SCI 患者身上提取间充质干细胞,在细胞生产室中处理提取的细胞,然后将再生细胞注射到 SCI 的确切部位或脑脊液 (CSF) 中。因此,该技术可作为 SCI 的个性化治疗。\\n\\n欧盟委员会于 2022 年 9 月发布的一份报告显示,科学家正在开发使用基于石墨烯的植入物和虚拟现实 (VR) 游戏来治疗 SCI 的新方法,以帮助改善中风恢复。科学家们正在尝试这些新方法来逆转神经损伤,而一些研究人员正在尝试使用石墨烯等工程材料原位重塑脊髓的结构。石墨烯用于创建 3D 结构,可以巧妙地模仿脊髓的形态。因此,使用这种创新的工程材料和植入物成功地展现了对 SCI 患者的治疗潜力。基于植入物的再生和创新治疗方法正在成为欧洲和中东慢性疼痛市场脊髓刺激设备的新趋势。\\n\\n“欧洲和中东慢性疼痛市场脊髓刺激设备”根据产品类型、应用、最终用户和地区进行细分。根据产品类型,慢性疼痛市场的脊髓刺激装置分为可充电式和不可充电式。可充电细分市场在 2022 年占据最大的市场份额,预计该细分市场在 2022 年至 2030 年期间将录得显着的复合年增长率。根据应用,慢性疼痛市场的脊髓刺激装置可分为背部失败综合征、复杂区域疼痛综合征、退行性椎间盘疾病等。复杂区域疼痛综合征细分市场在 2022 年占据最大的市场份额,预计该细分市场在 2020-2030 年预测期内复合年增长率最高。就最终用户而言,慢性疼痛市场的脊髓刺激设备分为医院、门诊手术中心等。医院细分市场将在 2022 年占据更大的市场份额,预计 2022 年至 2030 年期间复合年增长率将更高。\\n\\n2023 年 9 月,Resonant Link 和 Cirtec Medical Corp 合作,为植入式医疗设备的未来提供动力。通过将 Resonant Link 的下一代无线电源与 Cirtec Medical 的专业产品设计、开发和制造服务相结合,这种合作关系将为医疗设备制造商提供最好的技术、完全集成的组件和更快的上市时间。

Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Strategic Insights

Strategic insights for Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-and-middle-east-spinal-cord-stimulation-devices-for-chronic-pain-market-strategic-framework.webp
Get more information on this report

Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Report Scope

Report Attribute Details
Market size in 2022 US$ 892.66 Million
Market Size by 2030 US$ 1,573.67 Million
Global CAGR (2022 - 2030) 7.3%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 产品类型
  • 可充电和不可充电
By 应用
  • 腰椎间盘突出症
  • 复杂性局部疼痛综合征
  • 退行性椎间盘疾病
By 最终用户
  • 医院
  • 门诊手术中心
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Boston Scientific Corp
  • Abbott Laboratories
  • Medtronic Plc
  • Curonix LLC
  • Biotronik SE & Co KG
  • Nevro Corp
  • Nalu Medical Inc
  • Cirtec Medical Corp
  • Synapse Biomedical Inc
  • Get more information on this report

    Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Regional Insights

    The regional scope of Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-and-middle-east-spinal-cord-stimulation-devices-for-chronic-pain-market-geography.webp
    Get more information on this report

    The List of Companies - Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market

    The List of Companies - Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market
    - Boston Scientific Corp
    - Abbott Laboratories
    - Medtronic Plc
    - Curonix LLC
    - Biotronik SE & Co KG
    - Nevro Corp
    - Nalu Medical Inc ?
    - Cirtec Medical Corp
    - Synapse Biomedical Inc
    Frequently Asked Questions
    How big is the Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market?

    The Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market is valued at US$ 892.66 Million in 2022, it is projected to reach US$ 1,573.67 Million by 2030.

    What is the CAGR for Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market by (2022 - 2030)?

    As per our report Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market, the market size is valued at US$ 892.66 Million in 2022, projecting it to reach US$ 1,573.67 Million by 2030. This translates to a CAGR of approximately 7.3% during the forecast period.

    What segments are covered in this report?

    The Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market report typically cover these key segments-

  • 产品类型 (可充电和不可充电)
  • 应用 (腰椎间盘突出症, 复杂性局部疼痛综合征, 退行性椎间盘疾病)
  • 最终用户 (医院, 门诊手术中心)
  • What is the historic period, base year, and forecast period taken for Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market?

    The Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Boston Scientific Corp
  • Abbott Laboratories
  • Medtronic Plc
  • Curonix LLC
  • Biotronik SE & Co KG
  • Nevro Corp
  • Nalu Medical Inc
  • Cirtec Medical Corp
  • Synapse Biomedical Inc
  • Who should buy this report?

    The Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market value chain can benefit from the information contained in a comprehensive market report.